Browsing Centre for Cancer Prevention by Subject "estrogen receptor positive breast cancer"
Now showing items 1-1 of 1
-
Residual risk assessment with the Breast Cancer Index (BCI) for prediction of late distant recurrence (DR) in patients from the TransATAC study.
(American Society of Clinical Oncology, 2018-05-20)Background: The Breast Cancer Index (BCI) is a gene-expression based signature comprised of two complementary functional domains: the molecular grade index (MGI) for tumor proliferation, and the HoxB13/IL17BR ratio (H/I) ...